Kind Pharmaceuticals LLC
Kind Pharmaceuticals LLC
Explore linked clinical trials.7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy | Cancer-Related Anemia | Not yet recruiting | Phase 2 | 2026-09-01 | NCT06075043 | |
| A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy | Chemotherapy Induced Anemia | Not yet recruiting | Phase 2 | 2026-09-01 | NCT06075030 | |
| A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia | Hemic and Lymphatic Diseases, anemia, hematologic disorder | Recruiting | Phase 3 | 2026-03-27 | NCT07494409 | |
| A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) | Hemic and Lymphatic Diseases, anemia, hematologic disorder | Recruiting | Phase 3 | 2026-03-27 | NCT07487727 | |
| A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Phase 2 | 2026-02-27 | NCT06304103 | |
| A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia | β -Thalassemia | Recruiting | Phase 2 | 2026-02-27 | NCT06302491 | |
| A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 1 | 2026-02-27 | NCT05187832 |